Publications by authors named "G B Gomez-Cruz"

Background: Educational attainment is associated with wellbeing and health, but patients with schizophrenia achieve lower levels of education than people without. Several effective interventions can ameliorate this situation. However, the magnitude of the education gap in schizophrenia and its change over time are unclear.

View Article and Find Full Text PDF

Previous studies have suggested that subjects participating in schizophrenia research are not representative of the demographics of the global population of people with schizophrenia, particularly in terms of gender and geographical location. We here explored if this has evolved throughout the decades, examining changes in geographical location, gender and age of participants in studies of schizophrenia published in the last 50 years. We examined this using a meta-analytical approach on an existing database including over 3,000 studies collated for another project.

View Article and Find Full Text PDF

Introduction: Recent studies have observed that patients with treatment-resistant schizophrenia as well as patients with schizophrenia who do not respond within a medication trial exhibit excess activity of the glutamate system. In this study we sought to replicate the within-trial glutamate abnormality and to investigate the potential for structural differences and treatment-induced changes to improve identification of medication responders and non-responders.

Methods: We enrolled 48 medication-naïve patients in a 4-week trial of risperidone and classified them retrospectively into responders and non-responders using clinical criteria.

View Article and Find Full Text PDF

Introduction: Widespread white matter abnormalities and alterations in glutamate levels have been reported in patients with schizophrenia. We hypothesized that alterations in white matter integrity and glutamate levels in individuals at clinical high risk (CHR) for psychosis are associated with the subsequent development of psychosis.

Methods: Participants included 33 antipsychotic naïve CHR (Female 7/Male 26, Age 19.

View Article and Find Full Text PDF
Article Synopsis
  • Autologous hematopoietic stem cell transplantation (HSCT) was performed on 617 MS patients to reset their immune systems, involving outpatient procedures with cyclophosphamide and rituximab conditioning.
  • A total of 401 females and 216 males, with a median age of 46, participated, including various types of MS: 259 with relapsing-remitting, 228 with secondary progressive, and 130 with primary progressive.
  • The study showed a 100% overall survival rate after 30 months, with 78% of patients experiencing improvement or stabilization in their disability status after 12 months.
View Article and Find Full Text PDF